Pulmonx Announces Closing of up to $60 Million Credit Facility

Refinancing Strengthens Capital Structure by Extending Debt Maturity and Providing Access to Additional Undrawn CapitalREDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced the closing of a five-year credit facility for up to $60 million with Perceptive Advisors. The credit facility consists of an initial $40 million term loan drawn at closing to refinance th ...